DRDO releases anti-Covid drug; reduces oxygen dependency in patients

The oral drug, 2-deoxy-D-glucose (2-DG), will be produced by Dr Reddy's Laboratories and is likely to reach hospitals in first week of June

Rajnath Singh, Harsh Vardhan

Union Defence Minister Rajnath Singh hands over to Health Minister Harsh Vardhan the newly launched anti-Covid drug 2DG, developed by DRDO, in New Delhi. (Photo: PTI)

Defence Minister Rajnath Singh released on Monday the first batch of a keenly awaited, anti-Covid-19 drug called 2-deoxy-D-glucose (2-DG). It has been developed by the Defence Research and Development Organisation

Also Read

Alembic's affiliate Rhizen bags US regulator nod for oral cancer drug

India's drug regulator approves DRDO's anti-Covid drug for emergency use

Indian Army soft-pedals light tank of DRDO-L&T for China border

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Healing a weak regulator

Delhi sees 6-week low in daily Covid cases; positivity rate at 8.4%

Andhra Pradesh reports 18,561 new coronavirus cases, 109 fatalities

Delhi HC permits hospitals to withdraw pleas on medical oxygen supplies

Remdesivir coordination lacking between Centre, state: Gujarat HC

'Karnataka facility can produce 40-50 mn Covaxin doses a month by Aug-end'

First Published: May 17 2021 | 5:29 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to